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Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical frequent disease. However, its pathogenesis still
needs further study, especially the mechanism at the molecular level. The recent identified novel protein post-
translational modification, lysine succinylation was reported involved in diverse metabolism and cellular processes.
In this study, we performed the quantitative succinylome analysis in the liver of NAFLD model to elucidate the
regulatory role of lysine succinylation in NAFLD progression.
Methods: Firstly, experimental model of NAFLD was induced by carbon tetrachloride injection and supplementary
high-lipid and low-protein diet. Then series histochemical and biochemical variables were determined. For the
quantitative succinylome analysis, tandem mass tags (TMT)-labeling, highly sensitive immune-affinity purification,
liquid chromatography-tandem mass spectrometry techniques were applied. Bioinformatics analysis including gene
ontology annotation based classification; Wolfpsort based subcellular prediction; function enrichment; protein-
protein interaction network construction and conserved succinylation site motifs extraction were performed to
decipher the differentially changed succinylated proteins and sites and p-value < 0.05 was selected as threshold.
Results: Totally, 815 succinylation sites on 407 proteins were identified, of which 243 succinylation acetylation sites
on 178 proteins showed changed succinylation level with the threshold fold change > 1.5. Theses differentially
changed succinylated proteins were involved in diverse metabolism pathways and cellular processes including
carbon metabolism, amino acid metabolism, fat acid metabolism, binding and catalyzing, anti-oxidation and
xenobiotics metabolism. Besides, these differentially changed succinylated proteins were prominently localized
to cytoplasm and mitochondria. Moreover, 8 conserved succinylation site motifs were extracted around the
succinylation sites.
Conclusions: Protein succinylation was an extensive post-translation modification in rat. The changed succinylation
level in diverse proteins may disturb multiple metabolism pathways and promote non-alcoholic fatty liver disease
development. This study provided a basis for further characterization of the pathophysiological role of lysine
succinylation in NAFLD progression, which laid a foundation for the innovation of novel NAFLD drugs and therapies.
Keywords: Non-alcoholic fatty liver disease, Lysine succinylation, Succinylome, Bioinformatics analysis
* Correspondence: Jianjie_chen@hotmail.com
1Department of liver disease, Hospital for Infectious Diseases of Pudong New
Area, Shanghai 201299, P. R. China
2Shuguang Hospital affiliated to Shanghai University of Traditional Chinese
Medicine, Shanghai 201203, P. R. China
© 2016 Cheng et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Cheng et al. Proteome Science  (2016) 14:3 
DOI 10.1186/s12953-016-0092-y
Background
Non-alcoholic fatty liver disease (NAFLD) is an insulin
resistance and genetic susceptibility related metabolic
stress induced liver injury, including non-alcoholic sim-
ple fatty liver (NAFL), non-alcoholic steatohepatitis
(NASH) and cirrhosis [1]. With the age of onset of obes-
ity and it induced metabolic disorder becoming younger,
the injury of NAFLD on liver gets progressively worse.
In 2009, investigation on 3175 adults in Shanghai indi-
cated that the rate of NAFLD was 17.29 % [2]. However,
the rate ascended to 23.3 % in Shanghai and increased
rapidly in the major cities of China in 2012 [3]. NAFLD
now is the second most common liver disease after viral
hepatitis in China [2, 3]. A well-known two-hit hypoth-
esis has been proposed for the demonstration of the
pathogenesis of NAFLD. According to this hypothesis,
excess fat accumulated in the liver firstly, then oxidative
stress and lipid peroxidation led to hepatic inflammation,
fibrosis and a progressive form NASH and to cirrhosis [4].
However, the underlying deep mechanisms are still un-
clear and approved pharmacological agents are unavailable
for NAFLD [4]. Undoubtedly, NAFLD places an enor-
mous economic burden on society and lowers the quality
of one’s life greatly. It’s profound to study NAFLD patho-
genesis and explore novel cure avenues.
Protein post-translational modifications (PTMs) are
important regulatory patterns in a multiple of cellular
events [5, 6]. PTMs are defined as covalent processing
events that change the properties of a protein by pro-
teolytic cleavage or by adding a modified group to
one or more amino acids, thus the activity stage,
localization, turnover and interactions with other pro-
teins were changed [7]. Among all the amino acids,
lysine is a frequent target to be modified, which can
be subjected to a variety of PTMs including methylation,
acetylation, biotinylation, ubiquitination, ubiquitin-like
modifications, propionylation and butyrylation [8–11]. In-
creasing novel PTMs were identified recent years. Identi-
fying various potential novel PTMs in diverse species and
demonstrating the biological roles of these novel PTMs in
organism have been a research hotspot, such as the study
of protein propionylation, butyrylation and succinylation
[9, 12, 13].
Recent studies indicated that some PTMs were closely
connected with liver diseases. Kendrick et al. studied lysine
acetylome in mice liver and found multiple hyper-
acetylated proteins were presented in the liver of high-fat
diet mice [14]. Albitar et al. reported that the ubiquitination
of certain proteins was related with chronic liver disease
and they developed an ubiquitin proteasome system profil-
ing for the diagnosis of chronic liver disease [15]. However,
the role of PTMs, especially some recently identified PTMs
such as lysine succinylation and lysine malonylation in liver
disease still need further study.
In the present study, we carried out the quantitative
analysis of lysine succinylation in the liver of NAFLD rat
model. A series of bioinformatics analysis were con-
ducted to explore the molecular mechanisms of NAFLD
genesis and progress, where the change of protein succi-
nylation level may be involved. We aim to explore the
effects of protein succinylation on the pathogenesis of
NAFLD and probe potential diagnostic biomarkers and/
or therapeutical targets of NAFLD by antibody based
immunoprecipitation affinity enrichment and HPLC-
MS/MS based proteome analysis.
Results
Morphological changes in NAFLD rat model
Initially, hemotoxylin and eosin (HE) staining was ap-
plied to observe the liver pathological changes in
NAFLD rats. The results showed that, in control group
(Fig. 1a), the structure of liver tissue was complete and
the structure of sinus hepaticus was clearly observed;
Cells in the tissue were with normal morphology and
presented radial arrangement with the central vein as
the center. In contrast, structures of liver acini hepatis in
NAFLD rats were disorganized, and cells in the liver
were degenerated with cytoplasm rarefaction and large
number of fat vacuoles (Fig. 1b). Further oil red O stain-
ing from frozen section indicated that few lipid droplets
were observed in the liver tissues of normal rats (Fig. 1c),
while lots of fused lipid droplets were presented in the
liver tissues of NAFLD rats (Fig. 1d).
Biochemical changes of NAFLD rat model
As shown in Table 1, the glycerin trimyristate (TG) con-
tent in the liver of NAFLD model was significantly
higher than that in the liver of normal control. What’s
worse, the serum alanine aminotransferase (AST), ala-
nine aminotransferase (ALT) and glutamyltranspetidase
(GGT) activities in NAFLD rats also ascended signifi-
cantly compared with the control group, which indicated
that liver dysfunction may have occurred in the NAFLD
model. Antioxidant index determination results indi-
cated that the activity of superoxide dismutase (SOD)
and the content of glutathione (GSH) declined signifi-
cantly in the NAFLD group while the content of malo-
naldehyde (MDA) increased significantly compared with
the control group, implying the liver of NAFLD rats suf-
fered severe oxidative damage. Overall, we constructed a
NAFLD rat model successfully.
General characterization of the quantitative succinylome
in rat liver tissues
A total of 815 succinylation sites on 407 proteins
were identified with two technical repeat experiments
(686 succinylation sites in the first experiment and
692 in the second one, among which 563 sites were
Cheng et al. Proteome Science  (2016) 14:3 Page 2 of 11
identified in both experiments). With the threshold fold
change > 1.5, 243 succinylation sites corresponding to 178
proteins showed different succinylation level in our two
technical repeat experiments (180 up-regulated succiny-
lated sites on 132 proteins, 94 down-regulated succiny-
lated sites on 46 proteins, NAFLD group compared with
normal control group). All the identified succinylated sites
and corresponding proteins were summarized in
Additional file 1.
GO annotation based classification and Wolfpsort
based subcellular prediction analysis were conducted
to investigate the nature of these differentially chan-
ged succinylated proteins (Fig. 2). The classification
result on category of biological process showed that
metabolic process and cellular process related pro-
teins were the two largest groups suffered changed
succinylation level. Molecular function analysis indi-
cated the major differentially changed succinylated
proteins were binding and catalytic activity related,
whose percentage was 45.9 % and 39.6 %, respectively.
Cellular component based classification analysis found
cell and organelle related proteins were the main pro-
teins with changed succinylation level while other cel-
lular component related proteins were relatively less
(Fig. 2a).
Subcellular location prediction result (Fig. 2b) showed
the majority of these differentially changed succinylated
proteins were localized to cytoplasm (38 %) and mito-
chondria (26 %), followed by nucleus (13.1 %), extracel-
lular (6.9), endoplasmic reticulum (ER, 6.9 %), cytonucl
(4.0 %), plasm (1.7 %) and peroxisome (1.1 %).
Enrichment analysis of the differentially changed
succinylated proteins
As shown in (Fig. 3a), on molecular functions ontology,
the top three enriched GO terms were oxidoreductase ac-
tivity, cofactor binding and coenzyme binding. The mark-
edly enriched cellular components were organelle
envelope, mitochondrion and envelope (Fig. 3a), signifying
mitochondrion and/or other enveloped structures may be
the place where the proteins were differentially succinyla-
tation modified with a relatively higher frequency. On the
ontology of biological processes, the majority of these
markedly enriched terms were concerned with the metab-
olism of small molecules, such as oxoacid, organic acid,
carboxylic acid, amino acid and lipid (Fig. 3a).
In the KEGG pathway enrichment analysis, the top
three enriched pathways were metabolic pathways, val-
ine, leucine and isoleucine degradation and carbon
Fig. 1 Tissue morphological characteristics in the liver of NAFLD rat model and normal control. HE staining in normal control (a) and Non-alcoholic fatty
liver disease (b); oil red O staining in normal control (c) and Non-alcoholic fatty liver disease (d)





Liver tissue TG content (mg/g) 12.4 ± 1.5 75.6 ± 13.4
Serum ALT activity (U/L) 47 ± 9 172 ± 37
Serum AST activity (U/L) 126 ± 11 295 ± 43
Serum GGT activity (U/L) 6 ± 1.5 58 ± 5.3
Liver tissue SOD activity (U/mg protein) 214 ± 35 106 ± 23
Liver tissue MDA content (mg/g protein) 19 ± 8 75 ± 23
Liver tissue GSH content (mg/g protein) 21 ± 3.7 9 ± 2.3
Notes: Each value is the mean± SE (n= 10) and p value less than 0.01 was regarded
as statistic significant
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metabolism. Besides, many other amino acid metabolism
and fat acid metabolism related pathways were also
enriched (Fig. 3b)
Pfam domain analysis revealed that the top two signifi-
cantly enriched terms were thiolase-like and thioredoxin-
like fold. In addition, thiolase C-terminal and thiolase, N-
terminal domain was also significantly enriched with high
confidence. What’s noticeable was that all the significantly
enriched protein domains contained active group with sul-
fur or sulphydryl (Fig. 3c). We infer the activity of some sul-
fur /sulphydryl containing proteins/enzymes may be
changed by succinylation or dysuccinylation and these
changes may be involved in the progression of NAFLD.
Protein protein interaction (PPI) network analysis
To illuminate the mechanism of protein succinylation
mediated NAFLD genesis and development, we con-
structed the PPI network for all the succinylated pro-
teins with STRING database and Cytoscape software
(Fig. 4). With MCODE plug-in toolkit, a total of 5 highly
enriched interaction clusters were obtained, which were
related with metabolism of xenobiotics by cytochrome
P450, oxidative phosphotylation and ribosome, prote-
asome, fatty acid degradation and valine, leucine and iso-
leucine degradation.
Characterization of succinylated lysine sites in rat liver
As shown in Fig. 5a, a total of 8 definitively conserved suc-
cinylation site motifs were defined, namely Ksu K*D,
LKsuP, DKsuD, KsuP, KKsu, RKsu, KsuD, DKsu (Ksu repre-
sents the succinylated lysine and * represents a random
amino acid residue). To determine whether there are spe-
cific amino acids adjacent to succinylated lysines, we
examined the amino acid sequences flanking succinylation
sites by heat'map (Fig. 5b). Aspartic acid (D), lysine (K)
and arginine (R) were overrepresented in the −1 position
of succinylation sites. D was also appeared in the +1 to +3
positions with high frequency while K and R appeared in
these positions with very low frequency. Besides, a special
amino acid, proline (P) appeared in the +1 position of suc-
cinylation sites frequently but seldom appeared in the −1
position. In addition, it seemed that Serine (S) was unwel-
comed surrounding the succinylation sites as its frequency
of occurrence was obviously lower than other amino acids
in both upstream and downstream of succinylation sites.
Secondary structure analysis showed that the succiny-
lation sites distribution was about 64.1 % in coil, 30.3 %
in helix, and 5.5 % in beta-strand (Fig. 5c).
Discussion
Lysine succinylation is a newly identified PTM and im-
pacts diverse metabolic pathways [16]. Recent protein
Fig. 2 GO annotation based function classification and Wolfpsort based subcellular localization prediction. Function distribution of the identified
differentially changed succinylated protein from GO analysis (a) and subcellular localization prediction from Wolfpsort (b). With the threshold
change fold > 1.5, all the 178 differentially changed succinylated proteins (The proteins with down-regulated or up-redulated succinylation level
in the Additional file 1, NAFLD/Control Ratio > 1.5 or <0.67) were used for these analysis
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succinylome studies in mouse liver and mouse embryonic
fibroblasts (MEFs) showed that proteins succinylation level
changes participated in fat acid metabolism related path-
ways such as fatty acid β-oxidation and long-chain fatty
acid transportation [16–18]. It was well known that various
fatty liver diseases including nonalcoholic simple fatty liver
and alcoholic fatty liver were highly related with liver fatty
acid metabolism dysfunction. Thus we investigated the
quantitative protein succinylome in NAFLD rat model, with
the purpose of exploring the possible roles of lysine succi-
nylation in NAFLD progression.
Firstly, we constructed a classical NAFLD rat model ac-
cording to previous report [19] and a series of histological,
physiological and biochemical variables were detected.
High fat and low protein diet induced over accumulation
of TG, disturbance of biochemical variables and serious
Fig. 3 Enrichment analysis of the differentially changed succinylated proteins. GO annotation based enrichment analysis (a), KEGG pathway enrichment
analysis (b) and domain enrichment analysis (c). With the threshold change fold > 1.5, all the 178 differentially changed succinylated proteins (The proteins
with down-regulated or up-redulated succinylation level in the Additional file 1, NAFLD/Control Ratio > 1.5 or <0.67) were used for these analysis. The GO
enrichment analysis were performed on the ontology of molecular function, cellular component and biological process. DAVID as selected as the tool and
the adjusted p-value less than 0.05 was chosen as cut-off criterion
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oxidative damage (Fig. 1 and Table 1), which was consist-
ent with previous report [19].
Lysine succinylome analysis identified 815 succinyla-
tion sites on 407 proteins in the liver tissues of NAFLD
rat model and normal control. Park et al. identified
1,675 sites from 436 proteins in liver tissues of Sirt5
knockout mouse [18]. The huge difference of the volume
of succinylated sites may be related with the knockout of
Sirt5 as Sirt5 can remove succinyl moieties from target
lysine and acts as a desuccinylase role [20]. Quantifica-
tion analysis indicated that approximately two thirds
proteins showed elevated succinylation level in NAFLD
group compared with control group. These hyper-
succinylated proteins may be involved in the genesis and
development of NAFLD.
The classification result (Fig. 2a) implied that changed
lysine succinylation level may have influenced many
metabolic processes and cellular processes in NAFLD
rat liver. GO and KEGG pathway enrichment analysis
(Fig. 3a and b) further supported this hypothesis as
many small molecules (oxoacid, organic acid, carboxylic
acid, amino acid, fatty acid and lipid etc.) metabolism
processes and pathways were significantly enriched. Pre-
vious studies have well demonstrated the role of abnor-
mal metabolism of aboveing metabolites in NAFAD
pathogenesis [21–23]. A recent study on mouse liver ly-
sine succinylome also revealed many lysine-succinylated
proteins were predominantly involved in fatty acid me-
tabolism, amino acid degradation and the tricarboxylic
acid cycle [16]. Here we infer the succinylation level
alteration (preferentially hyper-succinylation) on these
molecules metabolism related proteins and/or enzy-
moses may be a potential promoting mechanism of
NAFLD progression.
High proportion binding and catalytic related proteins
(Fig. 2a) and significantly enriched cofactor binding and
coenzyme binding terms (Fig. 3a) imply changed succi-
nylation level may perturb the normal catalyzing or
binding function of target proteins/enzymes. These pro-
teins/enzymes were succinylation modified, thus their
space structure, charge states and stability may be
altered and they can’t bind to their coenzymes or
Fig. 4 The protein-protein interaction network analysis. a the whole interaction network; b-f, the extracted significantly enriched function models.
With the threshold change fold > 1.5, all the 178 differentially changed succinylated proteins (The proteins with down-regulated or up-redulated
succinylation level in the Additional file 1, NAFLD/Control Ratio > 1.5 or <0.67) were used for these analysis. STRING database was used to annotate
functional interactions of all the identified differentially succinylated proteins. The MCODE plug-in toolkit was used to identify highly connected clusters
and the interaction network was visualized by Cytoscape software (version 3.0.1)
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cofactors successfully, which further disturbed their
binding ability and catalytic activity. Succinylation dis-
turbed substrate binding and enzyme catalytic activity
had been reported in isocitrate dehydrogenase [24].
What’s worse, succinylation adds a bigger structural
moiety than acetylation or methylation and it is likely to
lead to more significant changes in protein structure
[24], which may change the protein binding or catalyzing
activity seriously.
What’s noticeable was that oxidoreductase activity term
was the top significant enriched term in molecular func-
tion enrichment analysis; functional classification analysis
also identified 7 antioxidant ability related proteins. Cor-
respondingly, we observed aggravated reactive oxygen spe-
cies (ROS) stress and deteriorated anti-oxidation enzyme
system in NAFLD by biochemical variables determination.
We guess the changes of succinylation level on antioxi-
dant enzymes may be another important event in NAFLD
development. The antioxidant related proteins with chan-
ged succinylation level might be potential targets for
NAFLD treatment.
Subcellular location prediction result indicated cyto-
plasm located differentially changed succinylated pro-
teins accounted for the largest part, and then was the
mitochondria located proteins. In a recent study, cellular
compartment analysis of all the lysine-succinylated pro-
teins identified from Sirt5 knockout (KO) liver tissue
and mouse embryonic fibroblasts (MEFs) found mito-
chondria located succinylated proteins accounted for the
largest part while cytoplasm located proteins was the
second most proteins [18]. Another succinylome study
in mouse liver tissue also observed the similar trends
[16]. The difference of subcellular distribution may be
related with the different experiment materials or experi-
mental treatments. For example, Sirt5 is an inhibitor of
lysine succinylation in mitochondria [18], Sirt5 knockout
naturally induced more protein succinylation modifica-
tion in mitochondria.
PPIs are crucial for most cellular processes [25]. Vari-
ous PTMs can change the interactions among protein,
thus metabolism processes and cellular processes were
affected [7]. In the obtained 5 significantly enriched
function modules, we found function module metabol-
ism of xenobiotics by cytochrome P450, fatty acid deg-
radation and valine, leucine and isoleucine degradation
were also enriched in the preceding GO and KEGG en-
richment analysis, which implied their important roles
in NAFLD development.
Fig. 5 Properties of the succinylated peptides. a Succinylation motifs and conservation of succinylation sites. b Heat map of the amino acid
compositions of the succinylated site. c Distribution of succinylated lysines and all lysines in protein secondary structures. All the identified 815
succinylation sites (Additional file 1) were used for the analysis. Software motif-x was used to analysis the model of sequences constituted with
amino acids in specific positions of succinyl-21-mers (10 amino acids upstream and downstream of the site). The local secondary structures of
succinylated proteins were predicted by NetSurfP. P-value < 0.05 was considered significant for these analysis
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The score of interaction clusters metabolism of xeno-
biotics by cytochrome P450, oxidative phosphotylation
and ribosome were very high, signifying alteration of
succinylation level on these proteins may contribute to
the development of NAFLD. In the metabolism of xeno-
biotics by cytochrome P450 function module, most of
these interacted proteins belonged to the Cytochrome
P450 (CYP450) family or Glutathione S-transferase
(GST) family. These two families participated in the me-
tabolism of various metabolites together, especially the
metabolism of secondary metabolism such as steroids,
fatty acids, xenobiotics and so on [26–28]. Lysine succi-
nylation on the members of CYP450 family and GST
family may disturb various secondary metabolism and
induced NAFAD. This is consistent with the aforemen-
tioned classification and enrichment analysis as various
molecular metabolism related terms were significantly
enriched. The major proteins in oxidative phosphotyla-
tion and ribosome cluster were subunits of mitochon-
drial F0F1 ATP synthase and ribosome, which imply
succinylation on F0F1 ATP synthase and ribosome were
important events in NAFAD development. The energy
production and protein synthesis was likely to be inter-
fered by increased lysine succinylation modification in
the liver of NAFLD model.
In the motif analysis, we identified 8 definitively con-
served succinylation site motifs. Previous motif and
flanking amino acid sequence analysis in SIRT5 knock-
out mouse showed that positively charged amino acids
(lysine or arginine) were strongly excluded from posi-
tions −1 and +1 of the succinylation logo [17, 18]. Our
study indicated lysine and arginine were rare represented
in +1 position while over represented in the −1 position
of succinylation sites. Furthermore, the negatively
charged amino acid aspartic acid was highly represented
in the positions near succinylation sites (−1, +1, +2, +3).
In the secondary structure analysis, we observed a slight
bias for succinylation to occur in alpha helix regions and
a slight bias against beta-strand regions and coil regions,
which was similar with previous finding that succinyla-
tion sites have moderate local structural preferences for
helical regions and a moderate bias against strand and
coiled regions in mouse [16].
Conclusions
In conclusion, we performed the quantitative succiny-
lome analysis in the liver of NAFLD rat model. A total
of 815 succinylation sites from 407 proteins were identi-
fied, of which 243 succinylation sites corresponding to
178 proteins had shown changed succinylation level with
the threshold fold change > 1.5. Bioinformatics analysis
indicated that these differentially changed succinylated
proteins participated in various metabolism processes
and cellular processes including but not defining to
carbon metabolism, amino acid metabolism, fat acid me-
tabolism, binding and catalyzing, anti-oxidation and xe-
nobiotics metabolism. Alteration of succinylation level
on these metabolism and cellular processes related pro-
teins may have changed many normal metabolism path-
ways and promoted NAFLD progression. These proteins
with differential succinylation level could be the poten-
tial diagnose biomarkers/therapy targets for NAFLD
treatment. Besides, the hyper-succinylated proteins were
mainly localized to cytoplasm and mitochondria. Motif
analysis obtained 8 conserved succinylation site motifs,
namely Ksu K*D, LKsuP, DKsuD, KsuP, KKsu, RKsu, KsuD
and DKsu. This is the first quantitative succinylome ana-
lysis in the liver tissues of NAFLD rat model, which con-
fer a novel perspective for the elucidation of the
mechanism underling NAFLD genesis and development
as well as the innovation of new drugs and therapy ave-
nues to cure NAFLD.
Materials and Methods
Experiment design
The purpose of this study was to perform the quantita-
tive lysine succinylome analysis in the NAFLD rat
model. Firstly we established the rat model according to
previous report. After different treatments, the liver tis-
sue morphological observation and biochemical variables
measurement were conducted in both NAFLD model
group and normal control group. Then we performed
the quantitative succinylation analysis in the liver of
NAFLD rat model by using tandem mass tags (TMT)-la-
beling, antibody-based succinylated peptides affinity en-
richment and nano LC-MS/MS techniques. Lastly,
bioinformatics analysis were carried out for the system-
atic interpretation of the identified lysine succinylated
sites and succinylated proteins. Two technical repeats
were performed for the succinylome analysis.
Regents
All reagents unless otherwise stated were purchased from
Sigma (St. Louis, America). Alanine aminotransferase
(ALT), aspartate aminotransferase (AST), glutamyltran-
spetidase (GGT), glycerin trimyristate (TG), superoxide
dismutase (SOD), reduced glutathione (GSH) and malo-
naldehyde (MDA) assay kit were purchased from Nanjing
Jiancheng Bioengineering Institute (Nanjing, China). Anti-
succinyl lysine antibody agarose beads were purchased
from PTM Biolabs (Hangzhou, China).
Experimental animal model
The detailed description of the model establishment and
diet for rats were given in the Additional file 2. Twenty
male Wistar rats with SPF grades, weight range 170 ± 10
g were used in this study and the rat model was estab-
lished according to Yao et al. [19]. The animal studies
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and protocols were approved by the Experimental
Animal Ethics Committee of Hospital for Infectious
Diseases of Pudong New Area.
Liver tissue preparation
Four weeks after treatment, all rats were fasted but nor-
mally supplied with water for 24 h. Then rats were per-
formed peritoneal injection with 3 % pentobarbital
sodium according to injection dose to rat weight of
2 ml/Kg. Abdominal cavity of anesthetic rat was incised,
and then inferior vena cava blooding sampling was per-
formed with 10 ml syringe. After standing for 3 h at 4 °C,
blood samples were centrifuged at 5000 x g for 15 min.
Supernatant was saved at −80 °C for future use. Liver was
incised and two segments (1.0 cm x 1.0 cm x 0.3 cm) were
cut from right lobe of the liver. Two liver segments were
fixed in 10 % neutral formalin and embedded in opt-imum
cutting temperature compound (OCT). The remained
liver samples were saved at −80 °C for future use.
Morphologic observation
To observe liver tissues morphologic changes, the HE
staining [29] and red O staining [30] of liver segments
was performed according to previous description.
Biochemical Variable Determination
Activities of AST, ALT and GGT in serum, and TG con-
tent, MDA content, GSH content and SOD activity in
liver tissues from experimental rats were determined ac-
cording to the instructions provided by the assay kit [31].
Proteomic analysis
Sample preparation
The protein extraction of the rat liver tissues was per-
formed according to previous report [32] and digested
by trypsin (Promega) with the second digestion method
to ensure thorough digestion [33].
Briefly, the liver tissues were first grinded by liquid ni-
trogen and the powder was transferred to 5 mL centri-
fuge tube and precipitated with cold 10 % TCA/acetone
supplemented with 50 mM DTT, 0.1 % Protease Inhibi-
tor Cocktail Set IV and HDACinhibitor (50 mM sodium
butyrate, 30 mM nicotinamide, and 3 μM Trichostatin
A) for 2 h at −20 °C. After centrifugation at 20,000 g at
4 °C for 10 min, the resulting precipitate was washed
with cold acetone for three times and air dried. Then
the precipitate was re-suspended in lysis buffer (8 M
urea, 2 mM EDTA, 10 mM DTT) and sonicated three
times on ice using a high intensity ultrasonic processor
(Scientz) and the remaining debris was removed by
centrifugation.
The supernatant was reduced with 10 mM DTT for
1 h at 56 °C and alkylated with 55 mM IAA for 45 min
at room temperature in darkness. Afterwards, the
protein was precipitated with 3 volumes of pre-chilled
acetone for 30 min at −20 °C. After centrifugation, the
pellet was then dissolved in 0.5 M TEAB and sonicated
for 5 min. Repeat the centrifugation step and collect the
supernatant. Protein content in the supernatant was de-
termined with 2-D Quant kit according to the manufac-
turer’s instructions. The protein was then digested with
trypsin (Promega) at an enzyme-to-substrate ratio of
1:50 for 12 h at 37 °C. To insure complete digestion and
improve protein identification and characterization, add-
itional trypsin at an enzyme-to-substrate ratio of 1:100
was added, and the mixture was incubated for an add-
itional 4 h. After trypsin digestion, peptide was desalted
by Strata X C18 SPE column (Phenomenex) and
vacuum-dried. Then peptides were labeled with a 2-plex
TMT kit with the protocol of the manufacture.
Enrichment of succinylated lysine peptides
Enrichment of lysine succinylated peptides was imple-
mented by immunoprecipitation according to previous
report [34] and the anti-succinyl lysine antibody agarose
conjugated beads (PTM Biolab) was used with a ratio of
15 μL beads/mg protein.
Briefly, 5 mg tryptic peptides was re-dissolved in
NETN buffer NETN buffer (100 mM NaCl, 1 mM
EDTA, 50 mM Tris–HCl, 0.5 % NP-40, pH 8.0) and in-
cubated with anti-succinyl lysine antibody agarose con-
jugated beads (PTM Biolab) in a ratio of 15 μL beads/
mg protein at 4 °C overnight with gentle end-to-end ro-
tation. After incubation, the beads were washed four
times with NETN buffer and twice with purified water.
The bound peptides were eluted with 1 % trifluoroacetic
acid (TFA) and dried under a vacuum. The eluted pep-
tides were cleaned with C18 ZipTips (Millipore) in ac-
cordance with the manufacturer's instructions followed
by HPLC/MS/MS analysis.
LC-MS/MS
LC-MS/MS was performed according to previous report
[13] and the detailed process and parameters were
shown in Additional file 2.
Database Search
All the detailed parameters were shown in the Supporting
Information (Additional file 2). The protein and succinyla-
tion sites were identified using MaxQuant software (Ver-
sion. 1.0.13.13) and Andromeda search 172 engine (Version
1.4.1.2). Tandem mass spectra were searched against Uni-
prot_Rat database with reverse decoy database.
Succinylation Quantification
The quantification of the succinylated peptides and pro-
teins were calculated according to the TMT reporter ion
intensities with COMPASS v1.2.1.0 software [35]. All
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peptides with same succinylation patterns were grouped
together and their reporter ion intensities were summed.
The quantitative ratios were weighted and normalized by
the median ratio. The manufacturer’s recommended iso-
tope correction factors were used. Based on relative quan-
tification and statistical analysis, 1.5-fold change was set as
threshold for differentially changed succinylated proteins.
Bioinformatics Analysis
The databases and softwares for bioinformatics analysis
were shown in Additional file 2. When performing the
bioinformatics analysis, p-value < 0.05 was considered
significant.
Statistical methods
Data were processed by using SPSS 17.0. Measurement
data were indicated as mean ± SEM. Comparisons be-
tween groups were tested by One -Way ANOVA analysis
and statistical difference was determined when P < 0.05.
Additional files
Additional file 1: The summary of all the identified succinylation
sites and corresponding proteins. (XLSX 71 kb)
Additional file 2: The detailed description of the experiment methods,
including rat model establishment, mass spectrometric analysis
procedures and parameters, bioinformatics analysis softwares,
websites. (DOCX 18 kb)
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